Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
By Bhanvi Satija and Patrick Wingrove London: Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2 billion on Tuesday, lifting its shares nearly 5 per …